Genentech, a member of the Roche Group, has announced positive results from the Phase III CELESTIMO study evaluating Lunsumio in follicular lymphoma patients. The trial assessed Lunsumio, also known as mosunetuzumab, in
MoreAutomated cell therapy manufacturing specialist Cellares is joining forces with Taiwanese biotech GenomeFrontier Therapeutics to advance virus-free CAR-T production. The partnership will assess whether GenomeFrontier’s virus-free manufacturing process is compatible with Cellares’
MoreHDA’s Kala Shankle is addressing one of the most pressing open questions in pharmaceutical distribution: what national licensure will mean for wholesalers and third-party logistics providers. Shankle, speaking to the biggest unresolved
MoreAstraZeneca (AZN) and Daiichi Sankyo have secured a significant victory after their flagship antibody drug conjugate Enhertu was approved for NHS use in England and Wales. The drug value assessor for England
MoreDHL has broken ground on a new cold chain hub at Singapore’s Changi Airport, marking a significant expansion of its pharmaceutical logistics capabilities in Asia. The new facility underlines growing demand for
MoreVera Therapeutics (NASDAQ: VERA) has reported promising new phase 3 clinical data showing its treatment Trutakna successfully stabilises kidney function in patients with IgA nephropathy. The results represent a significant milestone for
MoreMarken UPS Healthcare Precision Logistics is expanding its Laboratory Advantage service line to address the rising complexity of clinical trials taking place across the globe. Laboratory logistics form the foundation of clinical
MoreBristol Myers Squibb (BMY) and Ono Pharmaceutical have filed a lawsuit against Amgen (AMGN) in Delaware federal court to block a proposed biosimilar of their cancer drug Opdivo. The suit, filed last
MorePharmaceutical manufacturers continue to face significant challenges understanding what affiliated fees actually buy within pharmacy benefit manager contracting structures. A Federal Trade Commission settlement with Express Scripts, announced on February 4, 2026,
MoreAbbVie (ABBV) and the PGA Tour have announced a landmark partnership, naming the pharmaceutical giant the Official Pharmaceutical Sponsor of the PGA Tour and the 2026 Presidents Cup. The centrepiece of the
More
